Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W. Russo

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Hepatology Communications|November 16, 2021
Impact of the Corona Virus Disease 2019 Pandemic on Hepatology Practice and Provider BurnoutMark W Russo, Ryan Kwok, Marina Serper, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|November 19, 2016
Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics StudyRaymond A Rubin, Mark W Russo, Kimberly A Brown, et al.
Journal of Clinical Gastroenterology|September 15, 2004
Interpretation of liver chemistries in adult donors after living donor liver transplantationMark W Russo, Dianne LaPointe-Rudow, Alex Teixeira, et al.
Hepatology (Baltimore, Md.)|February 24, 2005
Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trialNicholas J Shaheen, Eugene Stuart, Sarah M Schmitz, et al.
Digestive Diseases and Sciences|July 2, 2013
Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfectionMark W Russo, Tarun Narang, Lon Eskind, et al.
The American Journal of Gastroenterology|October 3, 2002
Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis CK Shiva Kumar, Mark W Russo, Alain C Borczuk, et al.
The American Journal of Gastroenterology|July 20, 2006
The burden of gastrointestinal and liver diseases, 2006Nicholas J Shaheen, Richard A Hansen, Douglas R Morgan, et al.
Journal of General Internal Medicine|July 26, 2024
Identifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary CareTed G Xiao, Lauren Witek, Richa A Bundy, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 4, 2003
Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donorsPaul J Gaglio, Srikar Malireddy, Brian S Levitt, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 5, 2006
Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidatesTilak U Shah, Richard C Semelka, Vasilis Voultsinos, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Hepatology Communications|November 16, 2021
Impact of the Corona Virus Disease 2019 Pandemic on Hepatology Practice and Provider BurnoutMark W Russo, Ryan Kwok, Marina Serper, et al.
Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation|November 19, 2016
Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics StudyRaymond A Rubin, Mark W Russo, Kimberly A Brown, et al.
Journal of Clinical Gastroenterology|September 15, 2004
Interpretation of liver chemistries in adult donors after living donor liver transplantationMark W Russo, Dianne LaPointe-Rudow, Alex Teixeira, et al.
Hepatology (Baltimore, Md.)|February 24, 2005
Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trialNicholas J Shaheen, Eugene Stuart, Sarah M Schmitz, et al.
Digestive Diseases and Sciences|July 2, 2013
Intravenous interferon administered during liver transplantation is not effective in preventing hepatitis C reinfectionMark W Russo, Tarun Narang, Lon Eskind, et al.
The American Journal of Gastroenterology|October 3, 2002
Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis CK Shiva Kumar, Mark W Russo, Alain C Borczuk, et al.
The American Journal of Gastroenterology|July 20, 2006
The burden of gastrointestinal and liver diseases, 2006Nicholas J Shaheen, Richard A Hansen, Douglas R Morgan, et al.
Journal of General Internal Medicine|July 26, 2024
Identifying and Linking Patients At Risk for MASLD with Advanced Fibrosis to Care in Primary CareTed G Xiao, Lauren Witek, Richa A Bundy, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 4, 2003
Increased risk of cholestatic hepatitis C in recipients of grafts from living versus cadaveric liver donorsPaul J Gaglio, Srikar Malireddy, Brian S Levitt, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 5, 2006
Accuracy of magnetic resonance imaging for preoperative detection of portal vein thrombosis in liver transplant candidatesTilak U Shah, Richard C Semelka, Vasilis Voultsinos, et al.
Pageof 13